Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barneveld RA, Keijzer W, Tegelaers FP, Ginns EI, Geurts van Kessel A, Brady RO, Barranger JA, Tager JM, Galjaard H, Westerveld A, and Reuser AJ (1983) Assignment of the gene coding for human beta-glucocerebrosidase to the region q21–q31 of chromosome 1 using monoclonal antibodies. Hum Genet 64: 227
Beutler E, and Grabowski G (2001) Gaucher’s disease. In: The metabolic and molecular bases of inherited diseases (Scriver C, Beaudet A, Valle D, and Sly WS, eds). New York: McGraw-Hill, pp 3635
Brady R, Kanfer J, and Shapiro D (1965) Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher’s disease. Biochem Biophys Res Commun 18: 221
Desnick RJ, and Schuchman EH (2002) Enzyme replacement and enhancement therapies: Lessons from lysosomal disorders. Nat Rev Genet 3: 954
Devine EA, Smith M, Arredondo-Vega FX, Shafit-Zagardo B, and Desnick RJ (1982) Regional assignment of the structural gene for human acid beta-glucosidase to q42 leads to qter on chromosome 1. Cytogenet Cell Genet 33: 340
Dickersin G (2000) Diagnostic electron microscopy. A text/atlas. New York: Springer
Ginns EI, Choudary PV, Tsuji S, Martin B, Stubblefield B, Sawyer J, Hozier J, and Barranger JA (1985) Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease. Proc Natl Acad Sci USA 82: 7101
Jordan S (1964) Electron microscopy of Gaucher cells. Exp Mol Pathol 3: 76
Rights and permissions
Copyright information
© 2005 Springer-Verlag/Wien
About this chapter
Cite this chapter
(2005). Gaucher’s Disease. In: Functional Ultrastructure. Springer, Vienna. https://doi.org/10.1007/3-211-26392-6_53
Download citation
DOI: https://doi.org/10.1007/3-211-26392-6_53
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83564-7
Online ISBN: 978-3-211-26392-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)